245 related articles for article (PubMed ID: 21483795)
1. Wnt5a regulates midbrain dopaminergic axon growth and guidance.
Blakely BD; Bye CR; Fernando CV; Horne MK; Macheda ML; Stacker SA; Arenas E; Parish CL
PLoS One; 2011 Mar; 6(3):e18373. PubMed ID: 21483795
[TBL] [Abstract][Full Text] [Related]
2. Ryk, a receptor regulating Wnt5a-mediated neurogenesis and axon morphogenesis of ventral midbrain dopaminergic neurons.
Blakely BD; Bye CR; Fernando CV; Prasad AA; Pasterkamp RJ; Macheda ML; Stacker SA; Parish CL
Stem Cells Dev; 2013 Aug; 22(15):2132-44. PubMed ID: 23517308
[TBL] [Abstract][Full Text] [Related]
3. Wnt5a regulates ventral midbrain morphogenesis and the development of A9-A10 dopaminergic cells in vivo.
Andersson ER; Prakash N; Cajanek L; Minina E; Bryja V; Bryjova L; Yamaguchi TP; Hall AC; Wurst W; Arenas E
PLoS One; 2008; 3(10):e3517. PubMed ID: 18953410
[TBL] [Abstract][Full Text] [Related]
4. Diverse roles for Wnt7a in ventral midbrain neurogenesis and dopaminergic axon morphogenesis.
Fernando CV; Kele J; Bye CR; Niclis JC; Alsanie W; Blakely BD; Stenman J; Turner BJ; Parish CL
Stem Cells Dev; 2014 Sep; 23(17):1991-2003. PubMed ID: 24803261
[TBL] [Abstract][Full Text] [Related]
5. SFRP1 and SFRP2 dose-dependently regulate midbrain dopamine neuron development in vivo and in embryonic stem cells.
Kele J; Andersson ER; Villaescusa JC; Cajanek L; Parish CL; Bonilla S; Toledo EM; Bryja V; Rubin JS; Shimono A; Arenas E
Stem Cells; 2012 May; 30(5):865-75. PubMed ID: 22290867
[TBL] [Abstract][Full Text] [Related]
6. Wnt5a cooperates with canonical Wnts to generate midbrain dopaminergic neurons in vivo and in stem cells.
Andersson ER; Saltó C; Villaescusa JC; Cajanek L; Yang S; Bryjova L; Nagy II; Vainio SJ; Ramirez C; Bryja V; Arenas E
Proc Natl Acad Sci U S A; 2013 Feb; 110(7):E602-10. PubMed ID: 23324743
[TBL] [Abstract][Full Text] [Related]
7. Wnt5a induces Ryk-dependent and -independent effects on callosal axon and dendrite growth.
Clark CE; Richards LJ; Stacker SA; Cooper HM
Growth Factors; 2014 Feb; 32(1):11-7. PubMed ID: 24471468
[TBL] [Abstract][Full Text] [Related]
8. Dynamic temporal and cell type-specific expression of Wnt signaling components in the developing midbrain.
Rawal N; Castelo-Branco G; Sousa KM; Kele J; Kobayashi K; Okano H; Arenas E
Exp Cell Res; 2006 May; 312(9):1626-36. PubMed ID: 16510140
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of midbrain dopaminergic neuron development by Wnt-1, Wnt-3a, and Wnt-5a.
Castelo-Branco G; Wagner J; Rodriguez FJ; Kele J; Sousa K; Rawal N; Pasolli HA; Fuchs E; Kitajewski J; Arenas E
Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12747-52. PubMed ID: 14557550
[TBL] [Abstract][Full Text] [Related]
10. Wnt5a mediates nerve growth factor-dependent axonal branching and growth in developing sympathetic neurons.
Bodmer D; Levine-Wilkinson S; Richmond A; Hirsh S; Kuruvilla R
J Neurosci; 2009 Jun; 29(23):7569-81. PubMed ID: 19515925
[TBL] [Abstract][Full Text] [Related]
11. Tiam1 regulates the Wnt/Dvl/Rac1 signaling pathway and the differentiation of midbrain dopaminergic neurons.
Čajánek L; Ganji RS; Henriques-Oliveira C; Theofilopoulos S; Koník P; Bryja V; Arenas E
Mol Cell Biol; 2013 Jan; 33(1):59-70. PubMed ID: 23109420
[TBL] [Abstract][Full Text] [Related]
12. Wnt/planar cell polarity signaling controls the anterior-posterior organization of monoaminergic axons in the brainstem.
Fenstermaker AG; Prasad AA; Bechara A; Adolfs Y; Tissir F; Goffinet A; Zou Y; Pasterkamp RJ
J Neurosci; 2010 Nov; 30(47):16053-64. PubMed ID: 21106844
[TBL] [Abstract][Full Text] [Related]
13. Wnt5a-treated midbrain neural stem cells improve dopamine cell replacement therapy in parkinsonian mice.
Parish CL; Castelo-Branco G; Rawal N; Tonnesen J; Sorensen AT; Salto C; Kokaia M; Lindvall O; Arenas E
J Clin Invest; 2008 Jan; 118(1):149-60. PubMed ID: 18060047
[TBL] [Abstract][Full Text] [Related]
14. Wnt5a induces simultaneous cortical axon outgrowth and repulsive axon guidance through distinct signaling mechanisms.
Li L; Hutchins BI; Kalil K
J Neurosci; 2009 May; 29(18):5873-83. PubMed ID: 19420254
[TBL] [Abstract][Full Text] [Related]
15. Frizzled3 Controls Axonal Polarity and Intermediate Target Entry during Striatal Pathway Development.
Morello F; Prasad AA; Rehberg K; Vieira de Sá R; Antón-Bolaños N; Leyva-Diaz E; Adolfs Y; Tissir F; López-Bendito G; Pasterkamp RJ
J Neurosci; 2015 Oct; 35(42):14205-19. PubMed ID: 26490861
[TBL] [Abstract][Full Text] [Related]
16. Wnts and Wnt inhibitors do not influence axon outgrowth from chicken statoacoustic ganglion neurons.
Fantetti KN; Zou Y; Fekete DM
Hear Res; 2011 Aug; 278(1-2):86-95. PubMed ID: 21530628
[TBL] [Abstract][Full Text] [Related]
17. Delayed dopaminergic neuron differentiation in Lrp6 mutant mice.
Castelo-Branco G; Andersson ER; Minina E; Sousa KM; Ribeiro D; Kokubu C; Imai K; Prakash N; Wurst W; Arenas E
Dev Dyn; 2010 Jan; 239(1):211-21. PubMed ID: 19795519
[TBL] [Abstract][Full Text] [Related]
18. Wnt5a-dopamine D2 receptor interactions regulate dopamine neuron development via extracellular signal-regulated kinase (ERK) activation.
Yoon S; Choi MH; Chang MS; Baik JH
J Biol Chem; 2011 May; 286(18):15641-51. PubMed ID: 21454669
[TBL] [Abstract][Full Text] [Related]
19. Efficient expansion and dopaminergic differentiation of human fetal ventral midbrain neural stem cells by midbrain morphogens.
Ribeiro D; Laguna Goya R; Ravindran G; Vuono R; Parish CL; Foldi C; Piroth T; Yang S; Parmar M; Nikkhah G; Hjerling-Leffler J; Lindvall O; Barker RA; Arenas E
Neurobiol Dis; 2013 Jan; 49():118-27. PubMed ID: 22940632
[TBL] [Abstract][Full Text] [Related]
20. Facilitation of axon outgrowth via a Wnt5a-CaMKK-CaMKIα pathway during neuronal polarization.
Horigane S; Ageta-Ishihara N; Kamijo S; Fujii H; Okamura M; Kinoshita M; Takemoto-Kimura S; Bito H
Mol Brain; 2016 Jan; 9():8. PubMed ID: 26772170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
